Get started
Author

Heba A. Hassan

Observed names: Hassan, Heba A., Heba Hassan, Heba  A. Hassan
ORCID: 0000-0002-7023-4481
Observed ORCID: 0000-0002-7023-4481
OpenAlex ID: A5101635611
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
2020 · Aliaa M. Mohassab, Heba A. Hassan, et al. · Bioorganic Chemistry · 130
New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity
2018 · Samar H. Abbas, Amer Ali Abd El-Hafeez, et al. · Bioorganic Chemistry · 76
Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations
2017 · Aliaa M. Mohassab, Heba A. Hassan, et al. · Bioorganic Chemistry · 67
Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors
2022 · Mohamed Hisham, Heba A. Hassan, et al. · Journal of Molecular Structure · 60
STAT3 transcription factor as target for anti-cancer therapy
2020 · Aliaa M. Mohassab, Heba A. Hassan, et al. · Pharmacological Reports · 59
JNK signaling as a target for anticancer therapy
2021 · Kamal S. Abdelrahman, Heba A. Hassan, et al. · Pharmacological Reports · 56
Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition
2021 · Abdelfattah Hassan, Mohamed Badr, et al. · Bioorganic & Medicinal Chemistry · 45
NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth
2019 · Tamer S. Kaoud, Aliaa M. Mohassab, et al. · European Journal of Medicinal Chemistry · 36
New quinoline/1,2,4-triazole hybrids as dual inhibitors of COX-2/5-LOX and inflammatory cytokines: Design, synthesis, and docking study
2021 · Aliaa M. Mohassab, Heba A. Hassan, et al. · Journal of Molecular Structure · 34
New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization
2023 · Hend A. A. Ezelarab, Taha F. S. Ali, et al. · Molecular Diversity · 32
PDF
Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold
2022 · Abdelfattah Hassan, Mohamed Badr, et al. · Bioorganic Chemistry · 32
A review of recent advances in anticancer activity and SAR of pyrazole derivatives
2025 · Heba A. Hofny, Mamdouh F. A. Mohamed, et al. · Archiv der Pharmazie · 30
PDF
1-Malonyl-1,4-dihydropyridine as a novel carrier for specific delivery of drugs to the brain
2008 · Heba A. Hassan, Mohamed Abdel-Aziz, et al. · Bioorganic & Medicinal Chemistry · 25
Design and synthesis of new quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
2023 · Aliaa  M. Mohassab, Heba  A. Hassan, et al. · Journal of Molecular Structure · 21
Design, synthesis, and biological investigation of quinoline/ciprofloxacin hybrids as antimicrobial and anti-proliferative agents
2022 · Hend A. A. Ezelarab, Heba A. Hassan, et al. · Journal of the Iranian Chemical Society · 21
PDF
Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemia
2023 · Hend A. A. Ezelarab, Taha F. S. Ali, et al. · BMC Chemistry · 20
PDF
Fluoroquinolones as Urease Inhibitors: Anti-Proteus mirabilis Activity and Molecular Docking Studies
2016 · Mohammed A. A. Abdullah, Rehab Mahmoud Abd El-Baky, et al. · American journal of microbiological research · 19
Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAFV600E: Design, Synthesis, and Antiproliferative Activity
2023 · Lamya H. Al-Wahaibi, Mohamed Hisham, et al. · Pharmaceuticals · 17
PDF
Novel antimicrobial ciprofloxacin-pyridinium quaternary ammonium salts with improved physicochemical properties and DNA gyrase inhibitory activity
2021 · Hend A. A. Ezelarab, Samar H. Abbas, et al. · Medicinal Chemistry Research · 13
Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids via the EGFR Inhibition Pathway
2023 · Mohamed Hisham, Heba A. Hassan, et al. · Anti-Cancer Agents in Medicinal Chemistry · 12
Development and Assessment of 1,5–Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK–2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation
2023 · Kamal S. Abdelrahman, Heba A. Hassan, et al. · Molecules · 9
PDF
Facile one-pot three-component synthesis of 4,6-diaryl-3,4-dihydropyrimidine-2(1H)-thiones under ultrasonic irradiation
2019 · Shymaa A. Abbass, Gamal A. I. Moustafa, et al. · Synthetic Communications · 9
Hydantoin derivatives: A review on their anticancer activities
2023 · moamen hassanin, Muhamad Mustafa, et al. · Octahedron Drug Research · 8
PDF
N‐Malonyl‐1,2‐dihydroisoquinoline as a Novel Carrier for Specific Delivery of Drugs to the Brain
2009 · Mohamed Abdel‐Aziz, Gamal El‐Din A. A. Abuo‐Rahma, et al. · Archiv der Pharmazie · 8
The main biotargets of indole or 2-oxoindole-based hybrids acting as promising antiproliferative agents
2023 · Heba Hassan, Samar Abbas, et al. · Journal of advanced Biomedical and Pharmaceutical Sciences · 5
PDF
Works count: 34
Citation count: 855
H-index: 17
I10-index: 20
Year
Topic
Type